Market Overview:
The global cerebral angiography market is expected to grow at a CAGR of 5.8% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cerebrovascular diseases, rising geriatric population, and technological advancements in the field of cerebral angiography. Based on type, the global cerebral angiography market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), ultrasound, nuclear imaging, and X-ray. MRI is expected to be the fastest-growing segment during the forecast period owing to its high accuracy and non-invasive nature. Based on application, hospitals are expected to account for the largest share of the global cerebral angiography market in 2018 followed by diagnostic imaging centres. However, diagnostic imaging centres are projected to be the fastest-growing segment duringthe forecast period dueto their growing demand for advanced diagnostic procedures such as CT and MRI scans.
Product Definition:
Cerebral angiography is a medical imaging technique used to visualize the arteries of the brain. It involves injecting a contrast agent into the blood vessels in order to make them visible on an X-ray image. Cerebral angiography can be used to diagnose and treat conditions that affect the blood vessels in the brain, such as stroke, aneurysm, and arteriovenous malformation (AVM).
Magnetic Resonance Imaging:
Magnetic resonance imaging (MRI) is an effective diagnostic tool for the evaluation of soft tissues in the body. It uses magnetic field and radio waves to produce images of organs, tissues, & bones without ionizing radiation. MRI provides detailed images of structures within the body with excellent sensitivity, specificity and accuracy.
Computed Tomography:
Computed tomography (CT) is a medical imaging technique that utilizes computer technology to generate two- and three-dimensional images of internal body organs, tissues, and bones. CT scans are painless; however, patients may experience shortness in breath or feel dizzy while undergoing the scan.
Application Insights:
Based on application, the global cerebral angiography market is segmented into hospitals, diagnostic imaging centers and others. The hospitals segment dominated the market in 2017 owing to factors such as availability of advanced healthcare facilities and highly skilled personnel. Cerebral angiography is mainly performed in hospital settings for diagnosis of stroke or other neurological conditions that require treatment by an interventional neurosurgeon.
The diagnostic imaging centers segment is expected to grow at a lucrative rate during the forecast period due to increasing demand for CEA due to its benefits over conventional methods such as CT or MRI scan used for detection of brain aneurysm. Diagnostic imaging centers offer various advantages including cost-effectiveness, minimal exposure time required per case, high accuracy resulting in lesser number of surgeries are needed post completion of CEA procedure etcetera¢â‚¬â„¢s which are likely drive its adoption over other methods during future years.
Regional Analysis:
North America dominated the global cerebral angiography market in 2017. This can be attributed to the presence of well-established healthcare facilities, availability of highly skilled neurovascular surgeons and increased adoption of technologically advanced products for diagnosis. Moreover, increasing prevalence of various neurological disorders such as stroke, brain aneurysm and others are contributing towards growth in this region.
Asia Pacific is expected to grow at a lucrative rate over the forecast period owing to factors such as improving healthcare infrastructure with an aim toward quality treatment at affordable costs coupled with growing awareness among individuals about early diagnosis & management resulting in improved patient survival rates which ultimately drives demand for diagnostic procedures including cerebral angiography. Furthermore, increasing number of product launches by key players is also anticipated to drive growth during the forecast period.
Growth Factors:
- Increasing incidence of stroke and other cerebrovascular diseases: The global cerebral angiography market is expected to grow at a CAGR of 5.5% during the forecast period due to the increasing incidence of stroke and other cerebrovascular diseases.
- Rising demand for minimally invasive procedures: The growth of the cerebral angiography market is also attributed to the rising demand for minimally invasive procedures, which offer several benefits over traditional open surgery such as shorter hospital stay, reduced pain, and faster recovery time.
- Technological advancements in diagnostic imaging equipment: Cerebral angiography is a complex procedure that requires high-quality diagnostic imaging equipment for accurate results. This has led to significant advancements in diagnostic imaging technology in recent years, fueling the growth of the global cerebral angiography market.
- Growing geriatric population: The global geriatric population is growing at a rapid pace due to advances in medical care and lifestyle changes, resulting in an increase in cases of stroke and other cerebrovascular diseases requiring treatment with cerebral angiography procedures..
Scope Of The Report
Report Attributes
Report Details
Report Title
Cerebral Angiography Market Research Report
By Type
Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Nuclear Imaging, X-ray
By Application
Hospitals, Diagnostic Imaging Centres, Others
By Companies
Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Koninklijke Philips N.V. (Netherlands)
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
183
Number of Tables & Figures
129
Customization Available
Yes, the report can be customized as per your need.
Global Cerebral Angiography Market Report Segments:
The global Cerebral Angiography market is segmented on the basis of:
Types
Magnetic Resonance Imaging, Computed Tomography, Ultrasound, Nuclear Imaging, X-ray
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Hospitals, Diagnostic Imaging Centres, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Siemens Healthineers (Germany)
- GE Healthcare (U.K.)
- Toshiba Medical Systems Corporation (Japan)
- Hitachi Medical Corporation (Japan)
- Samsung Medison (South Korea)
- Shimadzu Corp. (Japan)
- St. Jude Medical, Inc. (U.S.)
- TERUMO Corporation (Japan)
- Koninklijke Philips N.V. (Netherlands)
Highlights of The Cerebral Angiography Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Magnetic Resonance Imaging
- Computed Tomography
- Ultrasound
- Nuclear Imaging
- X-ray
- By Application:
- Hospitals
- Diagnostic Imaging Centres
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cerebral Angiography Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cerebral angiography is a procedure that uses X-rays to image the blood vessels in the brain. This can help doctors diagnose and treat conditions such as stroke, aneurysms, and tumors.
Some of the major companies in the cerebral angiography market are Siemens Healthineers (Germany), GE Healthcare (U.K.), Toshiba Medical Systems Corporation (Japan), Hitachi Medical Corporation (Japan), Samsung Medison (South Korea), Shimadzu Corp. (Japan), St. Jude Medical, Inc. (U.S.), TERUMO Corporation (Japan), Koninklijke Philips N.V. (Netherlands).
The cerebral angiography market is expected to register a CAGR of 5.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cerebral Angiography Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cerebral Angiography Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cerebral Angiography Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cerebral Angiography Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cerebral Angiography Market Size & Forecast, 2020-2028
4.5.1 Cerebral Angiography Market Size and Y-o-Y Growth
4.5.2 Cerebral Angiography Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Magnetic Resonance Imaging
5.2.2 Computed Tomography
5.2.3 Ultrasound
5.2.4 Nuclear Imaging
5.2.5 X-ray
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Hospitals
6.2.2 Diagnostic Imaging Centres
6.2.3 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cerebral Angiography Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cerebral Angiography Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Magnetic Resonance Imaging
9.6.2 Computed Tomography
9.6.3 Ultrasound
9.6.4 Nuclear Imaging
9.6.5 X-ray
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Hospitals
9.10.2 Diagnostic Imaging Centres
9.10.3 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Magnetic Resonance Imaging
10.6.2 Computed Tomography
10.6.3 Ultrasound
10.6.4 Nuclear Imaging
10.6.5 X-ray
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Hospitals
10.10.2 Diagnostic Imaging Centres
10.10.3 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Magnetic Resonance Imaging
11.6.2 Computed Tomography
11.6.3 Ultrasound
11.6.4 Nuclear Imaging
11.6.5 X-ray
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Hospitals
11.10.2 Diagnostic Imaging Centres
11.10.3 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Magnetic Resonance Imaging
12.6.2 Computed Tomography
12.6.3 Ultrasound
12.6.4 Nuclear Imaging
12.6.5 X-ray
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Hospitals
12.10.2 Diagnostic Imaging Centres
12.10.3 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Magnetic Resonance Imaging
13.6.2 Computed Tomography
13.6.3 Ultrasound
13.6.4 Nuclear Imaging
13.6.5 X-ray
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Hospitals
13.10.2 Diagnostic Imaging Centres
13.10.3 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cerebral Angiography Market: Competitive Dashboard
14.2 Global Cerebral Angiography Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Siemens Healthineers (Germany)
14.3.2 GE Healthcare (U.K.)
14.3.3 Toshiba Medical Systems Corporation (Japan)
14.3.4 Hitachi Medical Corporation (Japan)
14.3.5 Samsung Medison (South Korea)
14.3.6 Shimadzu Corp. (Japan)
14.3.7 St. Jude Medical, Inc. (U.S.)
14.3.8 TERUMO Corporation (Japan)
14.3.9 Koninklijke Philips N.V. (Netherlands)
